Citations 1
A Case of Adult Multisystem Inflammatory Syndrome Following COVID-19 Vaccine
Brown, Meghan, Garbajs, Nika Zorko , Mushtaq, Hisham, Jama, Abbas B, Rauf, Ibtisam , Mir, Mikael, Korsapati, Aishwarya Reddy, Jain, Shikha , Adhikari, Ramesh , Lal, Amos , Domecq, Juan Pablo , Goksoy, Sarah, Bartlett, Brian, Jain, Nitesh , Khan, Syed Anjum , Garbajs, Nika Z, Zec, Simon , Khedr, Anwar , Koritala, Thoyaja , Jain, Nitesh Kumar, Lal, Amos , Domecq Graces, Juan Pablo , Mir, Mikael, Gajic, Ognjen , Sharma, Amit
Journal of Community Hospital Internal Medicine Perspectives | July 9, 2022 | Volume: 12 | Issue: 4 | Pages: 7-13
Multisystem inflammatory syndrome is a life-threatening condition associated with elevated inflammatory markers and multiple organ injury. A diagnosis of exclusion, it has been reported after severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) in children and adults; recently it has been described in some post-COVID-19 vaccinated individuals. The prognosis with supportive care and immunomodulatory therapy is good, although some individuals may require treatment in the intensive care unit (ICU). Here we report a case of a 58-year-old man who developed multi-organ failure after receiving the second dose of the Moderna mRNA-1273 COVID-19 vaccine. He required critical organ support in the ICU. An extensive workup was done to rule out alternative infectious and inflammatory processes. Following a period of gradual in-hospital convalescence, our patient made a full recovery. To our knowledge, this is the first comprehensively described case of multisystem inflammatory syndrome associated with Moderna mRNA-1273 COVID-19 vaccine in an adult over 50 years of age.